Products
Explore our advanced sequencing products for turning complex molecular signals into high-confidence readouts across clinical testing, RNA quality control, and translational methylation programs.

This case study highlights the utility of 5x direct Whole Methylome Sequencing (dWMS) for multi-omic biomarker discovery in oncology. By downsampling 30x ONT datasets from ovarian, lung, and lymphoma tumor samples, we demonstrate that low-pass dWMS enables cost-effective, high-confidence detection of genome-wide CpG methylation and large structural variants (SVs). These findings position dWMS as a powerful platform for translational research and clinical assay development.